Separate Impact of Obesity and Glucose Tolerance on the Incretin Effect in Normal Subjects and Type 2 Diabetic Patients

Muscelli, Elza, Mari, Andrea, Casolaro, Arturo, Camastra, Stefania, Seghieri, Giuseppe, Gastaldelli, Amalia, Holst, Jens J., Ferrannini, Ele·2008·Diabetes
DOI 10.2337/db07-1315

Cited by (409)

Items 301–400 of 409

  1. Comment on: Villareal et al. (2009) TCF7L2 Variant rs7903146 Affects the Risk of Type 2 Diabetes by Modulating Incretin Action. Diabetes;59:479–485
    Filip Krag Knop · 2010 · Diabetes
  2. Gut Peptide Alterations in Type 2 Diabetes and Obesity: A Narrative Review
    Evangelia Tzeravini, Stamatia Simati, Ioanna A. Anastasiou, Μaria Dalamaga, Alexander D. Kokkinos · 2026 · Current Obesity Reports
  3. Glycemic Impact of Non-Nutritive Sweeteners in Health and Type 2 Diabetes
    Braden D Rose, Denise Kreuch, Tongzhi Wu, Horowitz, Christopher Keith Rayner, Amanda J. Page, C. Miller, Richard L. Young · 2026 · Nutrition Reviews
  4. Role of endogenous incretin hormones, GLP-1 and GIP, in cardiovascular physiology
    Khushali Trivedi, Vernon Wayne Dolinsky · 2026 · Canadian Journal of Physiology and Pharmacology
  5. The Change in Glucagon Following Meal Ingestion Is Associated with Glycemic Control, but Not with Incretin, in People with Diabetes
    Soyeon Yoo, Dong‐Kyu Kim, Gwanpyo Koh · 2021 · Journal of Clinical Medicine
  6. The Associations Between Serum Concentrations of Irisin and Glucose-dependent Insulinotropic Polypeptide with Body Mass Index Among Women with and Without Polycystic Ovary Syndrome
    Samira Behboudi‐Gandevani, Mehdi Hedayati, Mohammad Alì Mansournia, Maryam Nazemipour, Maryam Rahmati, Fahimeh Ramezani Tehrani · 2021 · Intern J Endocrinol Metab
  7. The β-cell burden index of food: A proposal
    Francesca Scazzina, Alessandra Dei, Daniele Del Rio, Furio Brighenti, Riccardo C. Bonadonna · 2016 · Nutrition Metabolism and Cardiovascular Diseases
  8. Elevated Glucagon-like Peptide-1 and a Th2 Shift May Support Reduced Prevalence of Thoracic Aortic Aneurysm in Patients with Diabetes
    Stelia Ntika, Harshitha Jois, Karin Lång, Christian Olsson, Anders Franco‐Cereceda, Hanna M. Björck, Camilla Krizhanovskii · 2021 · Journal of Cardiovascular Development and Disease
  9. Diabetes and obesity. The role of agonists glucagon-like peptide-1 of in the treatment of type 2 diabetes
    Nina Alexandrovna Petunina, Тельнова Милена Эдуардовна · 2018 · Diabetes Mellitus
  10. Normal β‐cell function
    Andrea Natali, Stefano Del Prato, Andrea Mari · 2015 · Wiley eBooks
  11. Insulin Resistance: The Cardiovascular Aspect
    Helena Domínguez, Allan Flyvbjerg · 2008 · Hormone and Metabolic Research
  12. The integrated incretin effect is reduced by both glucose intolerance and obesity in Japanese subjects
    Akihiro Hamasaki, Norio Harada, Atsushi Muraoka, Shunsuke Yamane, Erina Joo, Kazuyo Suzuki, Nobuya Inagaki · 2024 · Frontiers in Endocrinology
  13. Mechanistic implications of diabetes leading to bone pathology
    Monidipa Konar, Bhavneet Kaur, Sadhna Sharma · 2024 · Journal of Orthopaedic Reports
  14. Obesity and Diabetes Mellitus
    Kyuzi Kamoi, Hideo Sasaki · 2014 · Internal Medicine Open Access
  15. A Computational Method to Determine Glucose Infusion Rates for Isoglycemic Intravenous Glucose Infusion Study
    Karam Choi, Jung Chan Lee, Tae Jung Oh, Myeungseon Kim, Hee Chan Kim, Young Min Cho, Sungwan Kim · 2015 · IEEE Journal of Biomedical and Health Informatics
  16. Adipositas und Diabetes
    Jens Aberle, Anne Lautenbach, Svenja Meyhöfer, Sebastian Michael Schmid, Lars Selig, Matthias Blüher · 2020 · Diabetologie und Stoffwechsel
  17. Incretin Based Therapies in Type 2 Diabetes Mellitus
    Uğur Alp Göksu, Aysun Ünal · 2017 · Kafkas Journal of Medical Sciences
  18. Oat β-glucan reshapes gut microbiota to enhance glucose homeostasis via coordinated modulation of bile acid conjugation and succinate-dependent intestinal gluconeogenesis
    Yantong Meng, Siqi Li, Keyi Zhou, Zhuoma Suonan, Zijian Dai, Qun Shen, Yong Xue · 2026 · Food Chemistry
  19. Response of low active GLP-1 like substances to test meal in obese Japanese patients with type 2 diabetes mellitus compared with obese controls with normal glucose tolerance
    Kyuzi Kamoi, Nobumasa Ohara, Tomoo Ikarashi, You Shinozaki, Kazuo Furukawa, Hideo Sasaki · 2012 · Journal of Diabetes Mellitus
  20. Obesity as a modifier of the cardiovascular effectiveness of sodium-glucose cotransporter-2 inhibitors in type 2 diabetes
    Karine Suissa, Sebastian Schneeweiß, Antonios Douros, Hui Yin, Elisabetta Patorno, Laurent Azoulay · 2022 · Diabetes Research and Clinical Practice
  21. Is Endogenous GLP-1 the Only Important Enhancer of Glucose-Induced Insulin Secretion in Type 2 Diabetes?
    Carolyn Fiona Deacon · 2012 · Diabetes
  22. Glucagon-like peptide-1 profile during oral glucose tolerance test in young people
    Sylwia Płaczkowska, Izabela Kokot, Lilla Pawlik-Sobecka, Agnieszka Piwowar · 2017 · Clinical Diabetology
  23. Sleeping oxygen saturation, rapid eye movement sleep, and the adaptation of postprandial metabolic function in insulin sensitive and resistant individuals without diabetes
    Karin A. Garcia, William K. Wohlgemuth, Ele Ferrannini, Andrea Mari, Alex Gonzalez, Armando J. Mendez, Roberto Bizzotto, Jay S. Skyler, Neil Schneiderman, Barry E. Hurwitz · 2018 · Physiology & Behavior
  24. Effects of Different Intensity Exercise on the Patients of Oxidative Stress Factors and Glycemic Control Type 2 Diabetes Mellitus
    Hu Wang, Yongbo Wang · 2022 · Mathematical Problems in Engineering · Retracted
  25. Methods to Assess In Vivo Insulin Sensitivity and Insulin Secretion
    Riccardo C. Bonadonna, Linda Boselli, Alessandra Dei, Maddalena Trombetta · 2018 · Endocrinology
  26. Ghrelin and glucagon-like peptide-1 according to body adiposity and glucose homeostasis
    Karynne Grutter Lopes, Vicente Lopes da Silva, Fernanda de Azevedo Marques Lopes, Eliete Bouskela, Maria das Graças Coelho de Souza, Luiz Guilherme Kraemer‐Aguiar · 2023 · Archives of Endocrinology and Metabolism
  27. Inadequate Triglyceride Management Worsens the Durability of Dipeptidyl Peptidase-4 Inhibitor in Subjects with Type 2 Diabetes Mellitus
    Masashi Shimoda, Maiko Miyoshi-Takai, Shintaro Irie, Akihito Tanabe, Atsushi Obata, Seizo Okauchi, Hidenori Hirukawa, Tomohiko Kimura, Kenji Kohara, Shinji Kamei et al. · 2017 · Journal of Diabetes Research
  28. Pengaruh Pemberian Susu Tinggi Protein terhadap Tingkat Nafsu Makan dan Kadar Glukosa Postprandial
    Harna Harna, Clara Meliyanti Kusharto, Katrin Roosita, Andi Muh Asrul Irawan · 2018 · Media Kesehatan Masyarakat Indonesia
  29. Medikamentöse Adipositastherapie – Chancen und Perspektiven
    Anne Lautenbach, Jens Aberle, Sebastian M. Meyhöfer, Svenja Meyhöfer · 2021 · Adipositas - Ursachen Folgeerkrankungen Therapie
  30. Non‐Insulin Parenteral Therapies
    Jens Juul Holst, Sten Madsbad, Ole Schmitz · 2010 · Wiley eBooks
  31. Developing and validating a new comprehensive glucose-insulin pharmacokinetics and pharmacodynamics model
    Ummu Kulthum Jamaludin · 2013 · UMP Institutional Repository (Universiti Malaysia Pahang)
  32. Postprandial Metabolic Responses to Macronutrient in Healthy, Hyperinsulinemic and Type 2 Diabetic Subjects
    Xiaomiao Lan‐Pidhainy · 2012 · TSpace (University of Toronto)
  33. Glucose metabolism and incretins level in morbidly obese patients and in patients after biliopancreatic diversion performed for morbid obesity
    Ivan Ivanovich Dedov, Galina Afanas'evna Mel'nichenko, Ekaterina Anatol'evna Troshina, Natalya Valentinovna Mazurina, Natalya Aleksandrovna Ogneva, Yu I Yashkov, А. В. Ильин · 2014 · Obesity and metabolism
  34. Clinical Approaches to Preserving β-Cell Function in Diabetes
    BERNARDO LEO WAJCHENBERG, Rodrigo Mendes de Carvalho · 2014 · Springer eBooks
  35. Endogenous Incretin Hormone Augmentation of Acute Insulin Secretion in Normoglycemic Relatives of Type 2 Diabetic Subjects: A 10-Year Retrospective Pathophysiological Study
    FRANK P. ALFORD, Christian Rantzau, Jan Erik Henriksen, Mette Brogaard Egede, Tina Trier Durck, Klaus Levin, Henning Beck‐Nielsen · 2014 · The Journal of Clinical Endocrinology & Metabolism
  36. Incretins: new targets for the prevention of diabetes and obesity
    Karl Neff, Carel Wynand le Roux · 2013 · Clinical Lipidology
  37. Enteral Nutrition and Glucagon-Like Peptide-1 in Intensive Care Unit Patients
    Okan Bakıner, Melek Eda Ertörer · 2014 · Springer eBooks
  38. Glucagon-Like Peptide 1 and Human Obesity
    Ananthi Anandhakrishnan, Márta Korbonits · 2017 · Elsevier eBooks
  39. Gut Hormones in Pregnancy and Lactation
    Jien Shim, Run Yu · 2019 · Elsevier eBooks
  40. Enteral Nutrition and Glucagon-Like Peptide-1 in Intensive Care Unit Patients
    Okan Bakıner, Melek Eda Ertörer · 2015 · Springer eBooks
  41. Obesity in the Pathophysiology of Diabetes
    Juan Antonio Paniagua, Antonio Vidal‐Puig · 2023 · Springer eBooks
  42. Association of GLP-1 secretion with parameters of glycemic control in women after gestational diabetes mellitus
    Eleni T. Pappa, Kristina Busygina, Saori Harada, Hana Hermann, Cornelia Then, Andreas Lechner, Uta Ferrari, Jochen Seißler · 2024 · BMJ Open Diabetes Research & Care
  43. Fasting GLP-1 Levels in Women with PCOS and CAH
    Ralitsa N. Robeva, G. Kirilov, Atanaska P. Elenkova, Sabina Zacharieva · 2024 · Acta Medica Bulgarica
  44. Is There any Interplay Between Incretins and Bile Acids? What is yhe Role of Bariatric Surgery?
    Alina Elena Pârvu, Florinela Catoi · 2014 · Medicine and Pharmacy Reports
  45. Enterohormones and the Response to Critical Illness
    Mark Philip Plummer, Annika Reintam Blaser, Adam M. Deane · 2016 · Springer eBooks
  46. Incretin System: New Pharmacological Target in Obese Women with Polycystic Ovary Syndrome
    Mojca Jensterle Sever, Simona Ferjan, Andrej Janež · 2018 · InTech eBooks
  47. Relationship between glucagon like peptide-1 and non-alcoholic fatty liver disease in diabetic and non-diabetic patients
    Nermin Sheriba, Merhan Samy Nasr, Caroline Adel, Samaa Anas · 2018 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
  48. The Gastrointestinal System and Obesity
    Gerardo Calderón, Andres J Acosta · 2019 · Elsevier eBooks
  49. Comparative assessment of metabolic, hormonal and psychological characteristics of young obese men
    Тельнова Милена Эдуардовна, Nina Alexandrovna Petunina · 2017 · Clinical Medicine (Russian Journal)
  50. Incretin Effects and Enteral Feed Transitions
    Ummu Kulthum Jamaludin, Paul D. Docherty, Jean‐Charles Preiser · 2015 · Springer eBooks
  51. Adipositas und Diabetes
    Jens Aberle, Anne Lautenbach, Svenja Meyhöfer, Sebastian M. Meyhöfer, Lars Selig, Matthias Blüher, Markus Menzen · 2022 · Die Diabetologie
  52. The blunted insulin release after exercise and the relationship with gastric inhibitory polypeptide and glucagon-like peptide-1
    Alison Glidden · 2010
  53. Response letter to comment on: Villareal et al. (2009) TCF7L2 Variant rs7903146 Affects the Risk of Type 2 Diabetes by Modulating Incretin Action. Diabetes; 59:479–485
    Dennis Tan Villareal, Kenneth S. Polonsky · 2010 · Diabetes
  54. Insulin resistance in pregnant mares: the influence of body condition
    Xiang Song · 2015 · The University of Queensland
  55. New Insights on the Interactions Between Insulin Clearance and the Main Glucose Homeostasis Mechanisms
    Roberto Bizzotto, Domenico Tricò, Andrea Natali, Amalia Gastaldelli, Elza Muscelli, Ralph A. De Fronzo, Silva A Arslanian, Ele Ferrannini, Andrea Mari · 2021
  56. Supersizing : a financial saving or threat to consumer health : the moderating role of nutritional labels
    Asim Shabir · 2019
  57. Role of Incretin, Incretin Analogues and Dipeptidyl Peptidase 4 Inhibitors in the Pathogenesis and Treatment of Diabetes Mellitus
    K. Athanasia, Marina S., I. Stavros · 2011 · InTech eBooks
  58. Enteral Nutrition in Open Abdomen After Injury
    Clay Cothren Burlew · 2015 · Springer eBooks
  59. Towards Modeling of Metabolic Syndrome: Tissue Crosstalk in Lipid Spillover
    Sergey Smirnov, Evgeny Metelkin, Nail M Gizzatkulov, Oleg Stepanov, Oleg O Demin · 2013 · Springer eBooks
  60. Molecular regulation of hormone secretion, growth and apoptosis of GLP-1-producing cells
    Camilla Kappe · 2012 · Figshare
  61. Response letter to comment on: Villareal et al. (2009) TCF7L2 Variant rs7903146 Affects the Risk of Type 2 Diabetes by Modulating Incretin Action. Diabetes;
    Trina Villareal, Kenneth S. Polonsky · 2010
  62. Cirurgia de bypass gástrico e Diabetes Mellitus Tipo 2 : Monografia : Gastric Bypass Surgery and Type 2 Diabetes Mellitus
    Raquel Maria de Coelho Lima · 2010
  63. Correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro
    Henrike Sell, Matthias Bl, Raphaela Schlich, Miriam Willems, Florian Ruppe, Wolfram Trudo Knoefel, Arne Dietrich, Barbara A. Fielding, Peter Arner, Keith N. Frayn et al. · 2013
  64. Islet-Cell Antibody Positive vs Negative Phenotypic Type 2 Diabetes Mellitus (T2DM) in Youth: Does the Oral Glucose Tolerance Test (OGTT) Distinguish Between the Two? Running Title: T2DM, Antibody status, OGTT and -cell function
    Hala Mounir Tfayli, Fida F Bacha, Neslihan Gungor, Silva A Arslanian · 2009
  65. Diabetological Assessment of Metabolic Surgery
    Janusz Gumprecht, Katarzyna Nabrdalik · 2012 · Springer eBooks
  66. Biochemical and molecular targets of novel antidiabetic agents
    Amar Bahadur Singh · 2009 · INFLIBNET
  67. Obesity and Metabolic Syndrome: Etiopathogenic Analysis
    Emilio González‐Jiménez, Gerard E. Mullin · 2014 · Springer eBooks
  68. Глюкозозависимый инсулинотропный полипептид новое звено в развитии ожирения
    Ekaterina Alekseevna Shestakova, А. В. Ильин, Марина Владимировна Шестакова, И. И. Дедов · 2015 · CyberLeninK (CyberLeninka)
  69. The Effect of Insulin and Insulin Resistance on Glucagon-like Peptide-1 Secretion from the Intestinal L Cell
    Gareth E. Lim · 2010 · TSpace (University of Toronto)
  70. Impact of bariatric surgeries on diabetes outcomes
    Elza Muscelli, Hugo Muscelli Alecrim · 2014
  71. Clinical Approaches to Preserving b-Cell Function in Diabetes 33
    BERNARDO LEO WAJCHENBERG, Rodrigo Mendes de Carvalho · 2015
  72. Adapting L-Cells to the Rescue!
    Jeffrey Gagnon · 2016 · Endocrinology
  73. The Acute Regulation of Intestinal Chylomicron Secretion by Glucagon-like Peptides
    Joanne Hsieh · 2012 · TSpace (University of Toronto)
  74. Relationships of gastric emptying with glycaemia, insulin secretion and the incretin effect in health and type 2 diabetes
    Chinmay S. Marathe · 2016 · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
  75. Integrating -omics information with biosimulations to assist diagnosis and treatment of diabetes mellitus in silico
    Clyde F. Phelix, Greg Villareal, Richard G. LeBaron, Dawnlee J. Roberson · 2017 · IEEE-EMBS International Conference on Biomedical and Health Informatics (BHI ...)
  76. A modulação crônica do receptor de GLP-1 altera aos níveis pressóricos, a estrutura e a função renal de ratos espontaneamente hipertensos
    Gabriela Cozin Aragão · 2017 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  77. The Effect of Micro Element Levels in Drinking Water on Adolescent Body Composition
    İhsan Çetin, Aydan Nazik, Mahmut Tahir Nalbantçılar, Kezban Tosun · 2017 · Kafkas Journal of Medical Sciences
  78. Avaliação do metabolismo glicêmico e perfil entero-hormonal no pós-operatório precose em pacientes abesos graves diabéticos submetidos à gastroplastia em Y de Roux.Comparação da oferta alimentar por via oral e por gastrostomia
    Gustavo Fernandes · 2017
  79. New pharmacological approaches in type 2 diabetes mellitus
    Kenneth J. Cusi · 2009 · Dialnet (Universidad de la Rioja)
  80. Effects of Exercise on Incretin Hormones
    Saeed Reza Toghi-Eshghi · 2018 · ERA: Education and Research Archive (University of Alberta)
  81. Efeitos da manipulação aguda dos ácidos graxos na secreção de insulina induzida pelas incretinas em voluntários com e sem diabetes tipo 2
    Valéria Bahdur Chueire · 2018
  82. Obesity in the Pathophysiology of Diabetes
    Juan Antonio Paniagua, Antonio Vidal‐Puig · 2019 · Springer eBooks
  83. Role of fasting duration and weekday in incretin and glucose regulation
    Kim Katrine Bjerring Clemmensen, Jonas Salling Quist, Dorte Vistisen, Daniel R. Witte, Anna Elisabet Jonsson, Oluf Borbye Pedersen, Torben F. Hansen, Jens Juul Holst, Torsten Lauritzen, Marit E. Jørgensen et al. · 2021 · Endocrine Abstracts
  84. Current literature in diabetes
    2008 · Diabetes/Metabolism Research and Reviews
  85. Clinical Approaches to Preserving β-Cell Function in Diabetes
    BERNARDO LEO WAJCHENBERG, Rodrigo Mendes de Carvalho · 2014 · Springer eBooks
  86. Efeito do sistema incretínico sobre o recrutamento de adipócitos bege
    Fernanda Cerqueira Barroso Oliveira · 2018
  87. Incretin Effects and Enteral Feed Transitions
    Ummu Kulthum Jamaludin, Paul D. Docherty, Jean‐Charles Preiser · 2014 · Springer eBooks
  88. New Insights on the Interactions Between Insulin Clearance and the Main Glucose Homeostasis Mechanisms
    Roberto Bizzotto, Domenico Tricò, Andrea Natali, Amalia Gastaldelli, Elza Muscelli, Ralph A. De Fronzo, Silva A Arslanian, Ele Ferrannini, Andrea Mari · 2021
  89. Fallimento β-cellulare nel diabete mellito di tipo 1 e di tipo 2: esistono meccanismi comuni?
    Nicola Marrano, Giuseppina Biondi, Francesco Giorgino, Annalisa Natalicchio · 2022 · il Diabete
  90. Therapie der Adipositas
    Anne Lautenbach, Clarissa Schulze zur Wiesch, Jens Aberle · 2022 · Die Diabetologie
  91. Dorzagliatin improves glucose-stimulated GLP-1 secretion in T2D and is synergistic with sitagliptin in glycemic control
    Li Chen, Jiayi Zhang, Yu Sun, Yu Zhao, Xiang Liu, Zhiyin Fang, Lingge Feng, Bin He, Quanfei Zou, Gregory Tracey · 2022 · Research Square
  92. Adipositas und Diabetes
    Jens Aberle, Anne Lautenbach, Svenja Meyhöfer, Sebastian M. Meyhöfer, Markus Menzen, Lars Selig, Matthias Blüher · 2022 · Diabetologie und Stoffwechsel
  93. Therapeutic Management of Type 2 Diabetes: The Nitric Oxide Axis
    Tara Ranjbar, Jennifer L. O’Connor, Khosrow Kashfi · 2022 · BENTHAM SCIENCE PUBLISHERS eBooks
  94. New Antidiabetic Agents: Relevance to Cardiovascular Outcomes
    Reinhold Hugo Kreutz, Engi Abd Elhady Algharably · 2023 · Updates in hypertension and cardiovascular protection
  95. Therapie der Adipositas
    Anne Lautenbach, Clarissa Schulze zur Wiesch, Jens Aberle · 2023 · Die Kardiologie
  96. Ormoni gastrointestinali e terapia del diabete: dalla fisiologia alle nuove opportunità terapeutiche
    Gian Paolo Fadini · 2023 · L Endocrinologo
  97. Adipositas und Diabetes
    Jens Aberle, Anne Lautenbach, Svenja Meyhöfer, Sebastian M. Meyhöfer, Markus Menzen, Lars Selig, Matthias Blüher · 2023 · Die Diabetologie
  98. The Story of Diabetes and its Causes
    Ramin Malboosbaf, Neda Hatami · 2023 · BENTHAM SCIENCE PUBLISHERS eBooks
  99. The entero-insular axis and metabolic syndrome
    Jit Sarkar, Partha Chakrabarti · 2024 · Elsevier eBooks
  100. Gut Hormones in Pregnancy and Lactation
    Jien Shim, Run Yu · 2025 · Elsevier eBooks